-+ 0.00%
-+ 0.00%
-+ 0.00%

Boundless Bio Q2 EPS $(1.06) Misses $(0.61) Estimate

Benzinga·08/10/2026 09:46:22
Listen to the news
Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(1.06) per share which missed the analyst consensus estimate of $(0.61) by 73.77 percent. This is a 51.43 percent decrease over losses of $(0.70) per share from the same period last year.